Skip Nav Destination
Issues
1 November 2002
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Editorials
The Biology Behind
Advances in Brief
Clinical Trials
In Vivo Validation of 3′deoxy-3′-[18F]fluorothymidine ([18F]FLT) as a Proliferation Imaging Tracer in Humans: Correlation of [18F]FLT Uptake by Positron Emission Tomography with Ki-67 Immunohistochemistry and Flow Cytometry in Human Lung Tumors1
Hubert Vesselle; John Grierson; Mark Muzi; Jeffrey M. Pugsley; Rodney A. Schmidt; Peter Rabinowitz; Lanell M. Peterson; Eric Vallières; Douglas E. Wood
Molecular Oncology, Markers, Clinical Correlates
Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
Clinical Trials
A Detailed Evaluation of Cardiac Toxicity: A Phase II Study of Doxorubicin and One- or Three-Hour-Infusion Paclitaxel in Patients with Metastatic Breast Cancer1
Sharon H. Giordano; Daniel J. Booser; James L. Murray; Nuhad K. Ibrahim; Zia U. Rahman; Vicente Valero; Richard L. Theriault; Marguerite F. Rosales; Edgardo Rivera; Debbie Frye; Michael Ewer; Nelson G. Ordonez; Aman U. Buzdar; Gabriel N. Hortobagyi
Reinfusion of Unprocessed, Granulocyte Colony-stimulating Factor-stimulated Whole Blood Allows Dose Escalation of 186Relabeled Chimeric Monoclonal Antibody U36 Radioimmunotherapy in a Phase I Dose Escalation Study1
David R. Colnot; Gert J. Ossenkoppele; Jan C. Roos; Jasper J. Quak; Remco de Bree; Pontus K. Börjesson; Peter C. Huijgens; Gordon B. Snow; Guus A. M. S. van Dongen
Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor in HLA-A2+ Patients with Metastatic Breast and Ovarian Cancer1
James L. Murray; Michael E. Gillogly; Donna Przepiorka; Hannah Brewer; Nuhad K. Ibrahim; Daniel J. Booser; Gabriel N. Hortobagyi; Andrzej P. Kudelka; Kenneth H. Grabstein; Martin A. Cheever; Constantin G. Ioannides
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Elevated Skp2 Protein Expression in Human Prostate Cancer: Association with Loss of the Cyclin-dependent Kinase Inhibitor p27 and PTEN and with Reduced Recurrence-free Survival1
Guang Yang; Gustavo Ayala; Angelo De Marzo; Weihua Tian; Anna Frolov; Thomas M. Wheeler; Timothy C. Thompson; J. Wade Harper
Pattern of Hormone Receptor Status of Secondary Contralateral Breast Cancers in Patients Receiving Adjuvant Tamoxifen
Thomas Bachleitner-Hofmann; Barbara Pichler-Gebhard; Margarethe Rudas; Michael Gnant; Susanne Taucher; Daniela Kandioler; Elisabeth Janschek; Peter Dubsky; Sebastian Roka; Emanuel Sporn; Raimund Jakesz
Expression of Epidermal Growth Factor Receptor Correlates with Disease Relapse and Progression to Androgen-independence in Human Prostate Cancer1
Giuseppe Di Lorenzo; Giampaolo Tortora; Francesco P. D’Armiento; Gaetano De Rosa; Stefania Staibano; Riccardo Autorino; Massimo D’Armiento; Michele De Laurentiis; Sabino De Placido; Giuseppe Catalano; A. Raffaele Bianco; Fortunato Ciardiello
Experimental Therapeutics, Preclinical Pharmacology
Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)1
Amy B. Heimberger; Chris A. Learn; Gary E. Archer; Roger E. McLendon; Tracy A. Chewning; Frank L. Tuck; John B. Pracyk; Allan H. Friedman; Henry S. Friedman; Darell D. Bigner; John H. Sampson
Suppression of Malignant Glioma Recurrence in a Newly Developed Animal Model by Endogenous Inhibitors1
Lorenzo Bello; Carlo Giussani; Giorgio Carrabba; Mauro Pluderi; Valeria Lucini; Marilou Pannacci; Dario Caronzolo; Giustino Tomei; Roberto Villani; Francesco Scaglione; Rona S. Carroll; Andreas Bikfalvi
Antitumor Activity of UCN-01 in Carcinomas of the Head and Neck Is Associated with Altered Expression of Cyclin D3 and p27KIP1
Vyomesh Patel; Tyler Lahusen; Chidchanok Leethanakul; Tadashi Igishi; Marcus Kremer; Leticia Quintanilla-Martinez; John F. Ensley; Edward A. Sausville; J. Silvio Gutkind; Adrian M. Senderowicz
Correction
Advertisement